Charles River Laboratories International Inc. Q4 Earnings Summary

Below are the earnings highlights for Charles River Laboratories International Inc. (CRL):

Earnings: -$214.50 million in Q4 vs. $187.08 million in the same period last year.
EPS: -$4.22 in Q4 vs. $3.62 in the same period last year.
Excluding items, Charles River Laboratories International Inc. reported adjusted earnings of $136.61 million or $2.66 per share for the period.

Analysts projected $2.53 per share
Revenue: $1.002 billion in Q4 vs. $1.013 billion in the same period last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com